Centaurus Financial Inc. Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Centaurus Financial Inc. bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 4,215 shares of the exchange traded fund’s stock, valued at approximately $416,000.

Other institutional investors have also recently modified their holdings of the company. Tidemark LLC boosted its position in SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares in the last quarter. ORG Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at approximately $40,000. Quintet Private Bank Europe S.A. purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at approximately $40,000. ORG Wealth Partners LLC acquired a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at $44,000. Finally, Howe & Rusling Inc. purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth $49,000.

SPDR S&P Biotech ETF Stock Up 1.2 %

XBI opened at $98.80 on Wednesday. The firm’s fifty day simple moving average is $98.37 and its two-hundred day simple moving average is $96.38. SPDR S&P Biotech ETF has a 52-week low of $71.99 and a 52-week high of $105.47. The company has a market cap of $7.53 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.